Back
Stoke Therapeutics Vs. Theriva Biologics Industry Stock Comparison
Sell
20
STOK
Stoke Therapeutics
Last Price:
$7.96
Seasonality Move:
18.62%
Sell
34
TOVX
Theriva Biologics
Last Price:
$1.29
Seasonality Move:
-9.97%
Sell
20
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy, Sell or Hold?
-
The current Stoke Therapeutics [STOK] share price is $8.01. The Score for STOK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
STOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
-
The current Theriva Biologics [TOVX] share price is $1.35. The Score for TOVX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $8.01Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.
STOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.77 | Sell |
Relative Strength Index (14 RSI): | 36.76 | Sell |
Chaikin Money Flow: | -13155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.04 - 11.42) | Sell |
Bollinger Bands (100): | (9.57 - 12.89) | Sell |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 44.66 | Sell |
Chaikin Money Flow: | -11219 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.31 - 1.57) | Sell |
Bollinger Bands (100): | (1.25 - 1.67) | Sell |
STOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.93 | Buy |
20-day SMA: | 9.2 | Sell |
50-day SMA: | 10.02 | Sell |
200-day SMA: | 12.75 | Sell |
8-day EMA: | 8.13 | Sell |
20-day EMA: | 8.88 | Sell |
50-day EMA: | 9.94 | Sell |
200-day EMA: | 11.25 | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.37 | Sell |
20-day SMA: | 1.47 | Sell |
50-day SMA: | 1.47 | Sell |
200-day SMA: | 3.33 | Sell |
8-day EMA: | 1.39 | Sell |
20-day EMA: | 1.43 | Sell |
50-day EMA: | 1.48 | Sell |
200-day EMA: | 3.8 | Sell |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.34 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
Stoke Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |